Search filters

Filters
Clear All

Phase

  • 1
  • 1
  • 5
  • 7
  • 3
  • 7

Found 7 biostatistics trials

A listing of biostatistics medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 Understanding the Genetics of Central Centrifugal Cicatricial Alopecia

Understanding the Genetics of Central Centrifugal Cicatricial Alopecia

All genders
The purpose of this study is to characterize gene mutations associated Central Centrifugal Cicatricial Alopecia (CCCA). The Penn Medicine BioBank (PMBB) supports researchers by providing centralized access to a large number of annotated blood and tissue samples. Clinician identified patients with CCCA and appropriate controls will be recruited from the …
 Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome (AEGIS-II)

Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome (AEGIS-II)

18-99 years
All genders
Phase 3
Interventional
This is a multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of CSL112 on reducing the risk of major adverse CV events (MACE) in subjects with Acute Coronary Syndrome (diagnosed with STEMI or NSTEMI), who are receiving evidence-based medical therapy.
 Addressing Barriers to Engagement with Harm Reduction Services for Opioid Overdose Prevention

Addressing Barriers to Engagement with Harm Reduction Services for Opioid Overdose Prevention

18-100 years
Healthy Volunteer
All genders
Help us understand how to better prevent harm in people who use drugs. If you are over 18, live or work in New York City, and have used drugs in the past 3 months, then you may qualify for a research study on your experiences with harm reduction health services. Eligible …
 Combination Ipatasertib and Atezolizumab to Prevent Recurrence in Triple Negative Breast Cancer

Combination Ipatasertib and Atezolizumab to Prevent Recurrence in Triple Negative Breast Cancer

18-99 years
All genders
Phase 2
The purpose of this study is to determine if a combination of two drugs, Ipatasertib and Atezolizumab, works as a treatment for residual cancer in breast or lymph nodes and have circulating tumor DNA in blood. Eligible subjects will be those with triple negative breast cancer.

UPCC 43422: Pembrolizumab and Involved Site Radiation Therapy for Early Stage Relapsed or Primary Refractory Hodgkin Lymphoma

All genders
Please refer to Protocol 17-054, Section 2.0 (Objectives and Scientific Aims) Please refer to Protocol 17-054, Section 14.0 (Biostatistics, Primary Endpoints) Please refer to Protocol 17-054, Section 14.0 (Biostatistics, Secondary Endpoints)

RURAL Heart and Lung Study

All genders
People living in impoverished counties in the rural South have the lowest life expectancy in the United States, and the highest mortality rates due to heart, lung, blood and sleep disorders, stroke, and cancer. RURALs innovative design seeks to overcome these challenges with its unique study design that brings resources …
 Utility of Parametric Response Mapping In Allograft Monitoring After Lung Transplant

Utility of Parametric Response Mapping In Allograft Monitoring After Lung Transplant

18-99 years
All genders
The purpose is to investigate whether parametric response mapping measurements in healthy lung allografts can be used for early detection, prognostication, and phenotyping of CLAD. The target population is bilateral lung transplant recipients who are 6 months post-transplant or later and CLAD free at any of the study institutions. At …